image
Exagen Inc. XGN
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 4.85
-1.34 %
$ 86.8 M
Market Cap
-5.34
P/E
Price Target Average
11.34%
Revenue Forecast Estimate
17.54%
EBIT Estimate
--39.99%
Net Income Estimate
22.19%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Exagen Inc.
image
Wall Street analysts predict an average 1-year price target for XGN of $5.4 , with forecasts ranging from a low of $5 to a high of $7 .
XGN Lowest Price Target Wall Street Target
5 USD 3.09%
XGN Average Price Target Wall Street Target
5.4 USD 11.34%
XGN Highest Price Target Wall Street Target
7 USD 44.33%
Price
Max Price Target
Min Price Target
Average Price Target
77665544332211Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25May '25May '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart XGN

image
$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.02019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart XGN

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)2019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart XGN

image
$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)2019201920202020202120212022202220232023202420242025202520262026202720272028202820292029